Cantitate/Preț
Produs
Total produse
Vezi coșul
Progress in Medicinal Chemistry de David R. Witty

Progress in Medicinal Chemistry: Progress in Medicinal Chemistry, cartea 59

Editat de David R. Witty, Brian Cox
en Limba Engleză Hardback – 5 mai 2020
Progress in Medicinal Chemistry, Volume 59, provides a review of eclectic developments in medicinal G139 chemistry. Each chapter is written by an international board of authors, with this release focusing on Small Molecules - Giant Leaps for Immuno-Oncology, Reviewing P2X7, Reviewing ASK1, and Reviewing DNA-encoded libraries.


  • Provides extended, timely reviews of topics in medicinal chemistry
  • Contains targets and technologies relevant to the discovery of tomorrow’s drugs
  • Presents analyses of successful drug discovery programs
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Hardback (6) 82958 lei  36-50 zile
  ELSEVIER SCIENCE – 18 mar 2019 82958 lei  36-50 zile
  ELSEVIER SCIENCE – 17 iun 2022 83031 lei  36-50 zile
  ELSEVIER SCIENCE – 5 mai 2020 83119 lei  36-50 zile
  ELSEVIER SCIENCE – 17 iun 2021 83616 lei  36-50 zile
  ELSEVIER SCIENCE – 20 mar 2017 86597 lei  36-50 zile
  ELSEVIER SCIENCE – 10 apr 2018 87061 lei  36-50 zile

Din seria Progress in Medicinal Chemistry

Preț: 83119 lei

Preț vechi: 121523 lei
-32%

Puncte Express: 1247
Preț estimativ în valută:
14699€ • 17250$ • 12749£

Carte tipărită la comandă

Livrare economică 02-16 martie

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă

Specificații

ISBN-13: 9780128211731
ISBN-10: 0128211733
Pagini: 260
Dimensiuni: 152 x 229 mm
Greutate: 0.52 kg
Editura: ELSEVIER SCIENCE
Seria Progress in Medicinal Chemistry

Public țintă

Everyone interested in the strategy and practice of the preclinical phases of the creation of new medicines. Those wishing to understand the drivers of drug design or expand their knowledge of therapeutic target classes

Cuprins

    1. Small molecules—Giant leaps for immuno-oncologyLisa Kötzner, Bayard Huck, Sakshi Garg and Klaus Urbahns
    2. P2X7 receptor antagonists for the treatment of systemic inflammatory disordersChristine F. Gelin, Anindya Bhattacharya and Michael A. Letavic
    3. Discovery and development of ASK1 inhibitorsReginald Brys, Karl Gibson, Tanja Poljak, Steven Van Der Plas and David Amantini
    4. An overview of DNA-encoded libraries—A versatile tool for drug discovery
Daniel Madsen, Carlos Azevedo, Iolanda Micco, Lars Kolster Petersen and Nils Jakob Vest Hansen